the use of separate sgc stimulants, scg activators and combinations with pde5 inhibitors for the treatment of multiple sclerosis (ssc) concurrent digital (du) ulcers

• 收藏
• 分享

专利权人:

BAYER PHARMA AKTIENGESELLSCHAFT

发明人:

ALEXANDROS VAKALOPOULOS,CLAUDIA HIRTH-DIETRICH,JOHANNES-PETER STASCH,MARKUS FOLLMANN,MICHAEL HAHN,PETER SANDNER

申请号：

BR112017023855

公开号：

BR112017023855A2

申请日:

2016.05.02

申请国别(地区):

BR

年份:

2018

代理人:

摘要：

use of scg stimulants, scg activators separately or in combination with pde5 inhibitors for the prevention and cure of digital ulcers that are concomitant with fibrotic diseases such as systemic sclerosis and scleroderma.uso de estimulantes de scg, ativadores de scg em separado ou em combinação com inibidores de pde5 para a prevenção e cura de úlceras digitais que são concomitantes às doenças fibróticas, como esclerose sistêmica e esclerodermia.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/